NCT01476098View on ClinicalTrials.gov

A Study to Investigate the Effect of SB-705498 on Chronic Cough

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

January 31, 2012

Conditions
Rhinitis
Interventions
DRUG

Placebo

SB-705498 placebo

DRUG

SB-705498

400 or 600mg oral SB-705498

Trial Locations (1)

M23 9QZ

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY